anonymous
Guest
anonymous
Guest
Chelsea's friends won't tell big pharma guy what is silly and what isn't. If he leaves, they will simply kiss the ass of the next person put in position. But that's OK, because we will get another useless slogan for the division, and spend a lot of money to buy data that tells us our customers still use birth control pills. Then we will rename our target list something new once more, and go call on the same customers that have always used the most iuds. Meanwhile we will have at least another price increase that we will tell our customer it's actually better for them. We will bring another year of efficacy for Mirena to the market, then ignore that many customers will tell the patient to just keep their iud in for another year, all the while wondering why our Mirena sales are down. Then in an act of brilliance, we will continue to try to sell kyleena at the same price of our 8 year device. Oh, but it's a premium product, so we can charge a premium price.
that’s pretty good!!! All true!!!